Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Melanoma × Colony-Stimulating Factors × Clear all

Phase

Phase 3 1 Phase 2/3 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 3 Neoplasm Metastasis 3 Triple Negative Breast Neoplasms 2 Prostatic Neoplasms 2 Osteosarcoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Lung Neoplasms 2 Ganglioneuroblastoma 2 Carcinoma, Non-Small-Cell Lung 2 Sarcoma 1 Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Melanoma 1 Medulloblastoma 1 Lymphoma, T-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Kidney Neoplasms 1 Hematologic Diseases 1 Gliosarcoma 1 Glioblastoma 1 Central Nervous System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Intraductal, Noninfiltrating 1 Burkitt Lymphoma 1 Breast Neoplasms 1

Interventions

Ipilimumab 90 Nivolumab 86 pembrolizumab 79 aldesleukin 62 Cyclophosphamide 40 Interleukin-2 38 trametinib 28 dabrafenib 27 fludarabine phosphate 26 Dacarbazine 26 Temozolomide 25 Vemurafenib 24 incomplete Freund's adjuvant 23 Bevacizumab 23 sargramostim 21 fludarabine 21 Radiosurgery 19 binimetinib 17 encorafenib 16 cobimetinib 15 Paclitaxel 15 Carboplatin 13 atezolizumab 12 Radiotherapy 12 Sorafenib 11 Biopsy 11 talimogene laherparepvec 10 montanide ISA 51 10 MART-1 Antigen 10 CTLA-4 Antigen 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01363206 2020-03-19

GIPI

Northern California Melanoma Center

Phase 2 Completed

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡